NICE guidance – updates

Keeping you up-to-datenice 1

Guidance by topic: the following guidance topics matching your health area preferences have been published or updated

 

Latest news from Eyes on Evidence

 Issue 51 – July 2013
This month in Eyes on Evidence
General health checks in adults

A Cochrane review suggests that general health checks are not associated with reductions in mortality or morbidity.

Hand eczema in healthcare workers 

A randomised controlled trial indicates that accurate diagnosis of hand eczema and a preventive education intervention in healthcare workers may improve symptoms and quality of life.
A systematic review suggests a lack of clear evidence for a relationship between negative mood and the premenstrual phase in the general population.
Adherence to a warfarin dosing algorithm by clinicians treating people with atrial fibrillation may be associated with improved coagulation control and clinical outcomes.
A retrospective observational study indicates that although short-term trends indicate a decline, longer-term data for 1971 to 2011 show a small increase in new medicine launches.
We highlight 2 new examples from the QIPP collection demonstrating how NHS organisations have implemented new local practices that have both cut costs and improved quality.
NICE has recently published Evidence Updates on:
  • Depression in children and young people
  • Surgical site infection

News from NICE

NICE recommends blood pressure device that can help prevent strokes

A new device that allows GPs and practice nurses to detect pulse irregularities and pick up cases of atrial fibrillation whilst measuring blood pressure has been recommended by NICE.   Atrial fibrillation (AF) causes the heart to beat with an irregular rhythm. It can be difficult to detect and subsequently diagnose as it is often asymptomatic and can be intermittent.

People with AF are at increased risk of developing blood clots and subsequent stroke, with 423,000 people aged 65 and over expected to have AF, of whom some will be will living with the condition yet are undiagnosed.

In its medical technology guidance on WatchBP Home A, NICE says the device reliably detects AF and may increase the rate of detection when used in primary care. This will consequently allow for preventative treatment to be given and to reduce the incidence of AF-related stroke.

Statement of collaboration between NICE and Public Heath England
NICE and Public Health England agreed to collaborate on future work.
February 8, 2013
Dementia, stroke and cancer among potential indicators for latest CCG Outcomes Indicator Set
Dementia, stroke, cancer, and end-of-life care are among 32 new indicators put forward for inclusion in the Clinical Commissioning Group Outcomes Indicator Set (CCG OIS).
February 4, 2013
Have your say on NICE’s social care work 
The Department of Health has launched a 12 week consultation to gather views on the topics for NICE’s new quality standards and guidance for social care.
February 1, 2013

An offer from BMJ – too good to refuse?

BMJ Learning is fast approaching two million module completions!

To celebrate, from 2-9 July, everyone will be able to access all of our modules for free – including journal related modules.

Plus, if you complete the two millionth module, you will win an iPad. We expect this module completion to happen this week.

Here are our latest and most popular modules which you could complete:

Atrial fibrillation (stroke prevention) – Rivaroxaban

Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation.  (Full Guidance (PDF))

Technology appraisals, TA256 – Issued: May 2012

NICE recommends rivaroxaban as a possible treatment to prevent stroke and systemic embolism in some people with atrial fibrillation (see below).

Who can have rivaroxaban?

You should be able to have rivaroxaban if you have atrial fibrillation without underlying heart valve disease and at least one of the following applies:

  • you have congestive heart failure (when the heart doesn’t pump blood as well as it should)
  • you have high blood pressure
  • you are 75 or older
  • you have diabetes
  • you have had a stroke or transient ischaemic attack (mini stroke) in the past.

via Atrial fibrillation (stroke prevention) – rivaroxaban.

Map of Medicine latest highlights

The latest evidence
Map of Medicine monitors over 150 guidance producers, and constantly searches over 3,000 sources for the latest meta-analyses and systematic reviews, enabling healthcare professionals to stay abreast of changes through a single resource. Over 40 care maps have been updated with the very latest evidence in our current issue, including:

Acute coronary syndrome: two new pieces of guidance from NICE incorporated. Ticagrelor added as a treatment option for selected patients. Management of hyperglycaemia, including testing, provision of information and lifestyle advice added for people with poor glycaemic control. 

Atrial fibrillation: new restrictions and monitoring requirements for the use of dronedarone in patients with atrial fibrillation, following MHRA Drug Safety Update.

Caesarean section: newly updated NICE recommendations including information on indications for caesarean section, including maternal request; and provision of evidence-based information and support for women.

Contraception: newly updated recommendations from the Faculty of Sexual and Reproductive Health (FSRH) on emergency contraception and combined hormonal contraception.

  • Athens users: visit the Map here and select ‘International’ / ‘England’ or your local view

NHS Evidence Jan-Feb updates (Cardio-respiratory)

An NHS Athens account may be required in some cases:

Added in February

Added in January